+1 (704) 266-3234

Abbott Laboratories (ABT) - Financial And Strategic SWOT Analysis Review

Published on: Mar 2017 | From USD $125 | Published By: GLOBAL DATA | Number Of Pages: 106

Abbott Laboratories (ABT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Abbott Laboratories (Abbott) is a healthcare company, which discovers, develops, manufactures, and sells a diversified range of healthcare products including drugs, diagnostics, branded generics, and vascular and nutritional products. The company’s drugs, diagnostic and nutritional products comprise specialized medicines; medical diagnostic instruments and tests; minimally invasive surgical devices; nutritional supplements for infants, children and adults; and products for veterinary care. It has research and development, manufacturing and administrative facilities across the world. The company markets its products in North America, Latin America, the Caribbean, the Middle East, Europe, Asia-Pacific and Africa. Abbott is headquartered in Abbott Park, Illinois, the US.

Abbott Laboratories Key Recent Developments

Jan 10, 2017: Abbott Announces CE Mark for its Alinity ci-series Diagnostic Systems
Oct 19, 2016: Abbott Reports Third-Quarter 2016 Results
Sep 08, 2016: Abbott Named Industry Leader For Responsible And Sustainable Business For Four Consecutive Years On The Dow Jones Sustainability Index
Aug 30, 2016: First randomized trial compares stenting techniques for coronary bifurcation
Jul 20, 2016: Abbott Reports Second-Quarter 2016 Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Section 1 - About the Company 6
Abbott Laboratories - Key Facts 6
Abbott Laboratories - Key Employees 7
Abbott Laboratories - Key Employee Biographies 9
Abbott Laboratories - Major Products and Services 10
Abbott Laboratories - Medical Equipment Pipeline Products Data 13
Abbott Laboratories Pipeline Products by Equipment Type 13
Abbott Laboratories Pipeline Products by Development Stage 14
Abbott Laboratories - History 34
Abbott Laboratories - Locations And Subsidiaries 50
Head Office 50
Other Locations & Subsidiaries 50
Section 2 – Company Analysis 70
Abbott Laboratories - Business Description 70
Business Description - Diagnostics 70
Diagnostics - Overview 70
Diagnostics - Financials 70
Business Description - Established Pharmaceutical Products 70
Established Pharmaceutical Products - Overview 70
Established Pharmaceutical Products - Financials 71
Business Description - Nutritionals 71
Nutritionals - Overview 71
Nutritionals - Financials 71
Business Description - Other Products 71
Other Products - Overview 71
Other Products - Financials 71
Business Description - Vascular 71
Vascular - Overview 71
Vascular - Financials 71
Abbott Laboratories - Corporate Strategy 72
Abbott Laboratories - SWOT Analysis 73
SWOT Analysis - Overview 73
Abbott Laboratories - Strengths 73
Abbott Laboratories - Weaknesses 74
Abbott Laboratories - Opportunities 75
Abbott Laboratories - Threats 76
Abbott Laboratories - Key Competitors 77
Section 3 – Company Financial Ratios 78
Financial Ratios - Capital Market Ratios 78
Financial Ratios - Annual Ratios 79
Performance Chart 81
Financial Performance 81
Financial Ratios - Interim Ratios 82
Financial Ratios - Ratio Charts 83
Section 4 – Company’s Lifesciences Financial Deals and Alliances 84
Abbott Laboratories, Medical Equipment, Deals By Year, 2011 to YTD 2017 84
Abbott Laboratories, Medical Equipment, Deals By Type, 2011 to YTD 2017 85
Abbott Laboratories, Recent Deals Summary 86
Section 5 – Company’s Recent Developments 87
Feb 09, 2017: St. Jude Medical Announces Cybersecurity Updates 87
Jan 25, 2017: Abbott Reports Fourth-Quarter 2016 Results 88
Jan 20, 2017: New Study Demonstrates Spinal Cord Stimulation Can Reduce or Stabilize Opioid Use Among Chronic Pain Patients 91
Jan 10, 2017: Abbott Announces CE Mark for its Alinity ci-series Diagnostic Systems 92
Dec 07, 2016: Abbott Seeks To Terminate Alere Acquisition 93
Oct 24, 2016: St. Jude Medical Announces Data to be Presented as Late-Breaking Clinical Trials and Highlights Its Latest Cardiovascular Portfolio at the 2016 TCT Conference 94
Oct 24, 2016: St. Jude Medical Recalls Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy Defibrillators Due to Premature Battery Depletion 95
Oct 19, 2016: Abbott Reports Third-Quarter 2016 Results 96
Oct 19, 2016: St. Jude Medical Reports Third Quarter 2016 Results 99
Oct 17, 2016: St. Jude Medical Announces it is Forming a Cyber Security Medical Advisory Board 101
Section 6 – Appendix 102
Methodology 102
Ratio Definitions 102
About GlobalData 106
Contact Us 106
Disclaimer 106

List of Figures
Abbott Laboratories Pipeline Products by Equipment Type 13
Abbott Laboratories Pipeline Products by Development Stage 14
Abbott Laboratories, Performance Chart (2012 - 2016) 81
Abbott Laboratories, Ratio Charts 83
Abbott Laboratories, Medical Equipment, Deals By Year, 2011 to YTD 2017 84
Abbott Laboratories, Medical Equipment, Deals by Type, 2011 to YTD 2017 85

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $125
USD $250
USD $375
Offer

Why Us

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.